https://tissuepathology.com Educational and informative Tue, 23 Jun 2026 13:17:57 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/06/23/spotlight-medical-secures-ivdr-ce-marking-for-mystage-dx-its-ai-enabled-prognostic-test-for-er-her2-early-breast-cancer/ Tue, 23 Jun 2026 13:17:57 +0000 https://tissuepathology.com/?p=24507 Spotlight Medical: Class C software-only IVD supports European rollout of a JCO-published assay designed to bring clinically validated prognostic assessment into routine breast cancer care. PARIS–(BUSINESS WIRE)–Spotlight Medical, a Paris-based oncology diagnostics company, today announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) […]

The post Spotlight Medical Secures IVDR CE Marking for myStage Dx, Its AI-Enabled Prognostic Test for ER+/HER2 – Early Breast Cancer first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/22/tribun-health-the-time-to-go-digital-is-now-and-its-more-achievable-than-you-think/ Mon, 22 Jun 2026 15:04:23 +0000 https://tissuepathology.com/?p=24503 From the Tribun Health blog: Discover why digital pathology adoption is accelerating and how laboratories can transition progressively toward scalable digital diagnosis. For several years now, digital pathology has been presented as the new way to practice pathology. The difference today is that this future has become reality, and laboratories making the transition are discovering that the […]

The post Tribun Health: The Time to Go Digital Is Now… and It’s More Achievable Than You Think first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/19/charles-river-joins-lilly-tunelab-to-optimize-ai-ml-platform-through-nonclinical-testing-expertise/ Fri, 19 Jun 2026 12:16:28 +0000 https://tissuepathology.com/?p=24500 Charles River and Lilly Tune Lab: Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to […]

The post Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/18/proscia-launches-fifth-generation-of-concentriq-bringing-the-latest-advancements-in-ai-to-pathologists-and-scientists/ Thu, 18 Jun 2026 15:22:57 +0000 https://tissuepathology.com/?p=24498 PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies. Pathology sits […]

The post Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/17/roche-receives-fda-approval-for-the-first-companion-diagnostic-to-assess-pten-protein-in-people-living-with-prostate-cancer/ Wed, 17 Jun 2026 11:42:11 +0000 https://tissuepathology.com/?p=24496 Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated with faster disease progression and reduced benefit from current standard-of-care treatments.1 The FDA approval reinforces Roche’s leadership […]

The post Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/16/leica-biosystems-launches-ai-powered-digital-pathology-solution-in-europe-middle-east-and-africa/ Tue, 16 Jun 2026 13:32:41 +0000 https://tissuepathology.com/?p=24494 Leica Biosystems: High-throughput Aperio GT Elite scanner with AI-enabled quality control supports digital and computational pathology workflows VISTA, CA – June 15, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, is expanding the availability of its Aperio GT Elite digital scanner into the EMEA (Europe, Middle East & […]

The post Leica Biosystems Launches AI-Powered Digital Pathology Solution in Europe, Middle East, and Africa first appeared on Tissuepathology.com.]]>